Reduced Number and Activity of Circulating Endothelial Progenitor Cells in Acute Aortic Dissection and Its Relationship With IL-6 and IL-17

This study investigates the alteration in function and number of circulating endothelial progenitor cells (EPCs) in patients with aortic dissection (AD), compared with hypertensive patients, and its possible mechanism. Thirty-four patients with acute aortic dissection (AAD) and 20 patients with primary hypertension were involved. Flow cytometry analysis was performed to detect the number of CD34+/KDR+ cells, and acetylated low density lipoprotein (ac-LDL) and lectin fluorescent staining method was applied to test the number of cultured EPCs. In addition, EPC migration and proliferation were measured, and plasma interleukin 6 (IL-6) and interleukin 17 (IL-17) levels were investigated. The number of circulating EPCs in the AAD group was lower than that in the non-AD group, and the proliferation and migration of circulating EPCs in the AAD group were lower than that in the non-AD group. In addition, the number, proliferation, and migration of circulating EPCs were significantly inversely correlated with the aortic dissection detection risk score (ADD-RS). More importantly, increased plasma IL-6 and IL-17 level was found in the AAD group, and the two inflammatory factors were inversely associated with the function and number of circulating EPCs in the AAD group. We first demonstrated that the number and function of circulating EPCs are reduced in the AAD group, which may be partly related to upregulated plasma IL-6 and IL-17. Our study provides novel insight on the underlying mechanism and potential therapeutic target of AAD.

Introduction

Aortic dissection (AD) is a serious disease threatening human life, which has rare incidence rate and extremely high mortality (1, 2). The incidence of acute aortic dissection (AAD) ranges from 3 to 6 per 100,000 patient-years in the general population in the United States, which has been increasing markedly, especially in recent years (3). It is well-known believed that the changes in the membrane structure and the function of critical cells in the aorta play an important role in the pathogenesis of AAD (4, 5). The aortic wall includes the intima, middle layer, and adventitia. The intimal rupture is one of the initial events of AD. Previous studies on the intimal layer of the aorta mainly concentrated in the pathogenesis of atherosclerotic stenosis such as coronary heart disease, and in recent years, the structure and function of the intimal layer of the aorta have been paid more attention (6, 7).

Aortic intima functions as critical factor to maintain the normal morphology and diastolic function of arteries (8). Some studies have shown that the damage and tear of vascular intima are the initial link of aortic dissection (9) and proved that the intima plays a crucial role in vascular injury and repair. Another study also have proven that vascular endothelial cell is damaged, promoting the formation of AD (10). Therefore, the repair of the intima may provide a novel way to intervene the pathological progress of aortic dissection.

Endothelial progenitor cells (EPCs) mobilized from bone marrow can directly differentiate into endothelial cells. They not only participate in the formation of early embryonic blood vessels but also participate in the regeneration of adult blood vessels (11, 12). EPCs are mainly involved in the development of the blood system and inflammatory immune response with inability for vascular regeneration, which can accelerate the repair in damaged vascular endothelium. EPCs have the characteristics of proliferation, migration, adhesion, and basement membrane matrix formation during the process of vascular repair (13, 14).

Many studies confirmed that metabolic abnormalities, smoking, and obesity can decrease circulating number and function of EPCs, reduce its ability to repair the endothelium, and cause endothelial dysfunction, which in turn give rise to the process of vascular diseases including hypertension (15–17). A systematic review summarized that 45–100% patients with acute aortic dissection have a most common comorbidity with hypertension (3). In our previous study, we found that the early stage of hypertension can cause EPC dysfunction (18, 19). Therefore, we speculate that endothelial injury may be the main cause of AAD.

Inflammation may be engaged in the development of AAD (20). During the process of AAD, inflammatory cells, such as phagocytes, can degrade elastic fibers by releasing matrix metalloproteinase (MMP), destroy the middle membrane of the aorta, and cause the thinning of the arterial wall, which leads to AD (21, 22). Interleukin 6 (IL-6) is an important proinflammatory factor, which can induce monocytes to differentiate into phagocytes (23). IL-6 was found to increase in acute aortic dissection, and when downregulating IL-6 expression, vascular macrophages production were decreased, thus delaying the occurrence of aortic dissection (24). Interleukin 17 (IL-17), a CD4+ T-helper subset, has been found to be involved in atherosclerosis and vascular dysfunction (25, 26). Previous study reported that IL-17 may function as a participant in AD pathogenesis by promoting inflammation (27). Thus, IL-6 and IL-17 may be related with AAD for its vascular inflammation.

This study is to explore the relationship between the function and number of EPC and aortic dissection detection risk score (ADD-RS) in AAD and hypertensive patients and analyze the level of IL-6 and IL-17 in the two groups. Our purpose is to find the potential molecular mechanism of AAD and a new intervention target for AAD prevention and treatment.

Materials and Methods

Subject Characteristics

Thirty-four patients suffering AAD, and 20 non-AD patients with essential hypertension were recruited. All patients older than 18 years admitted to the First Affiliated Hospital of Sun Yat-sen University were eligible. The definition of AD in our study was according to a previous study, which was majorly diagnosed by computed tomography (CT) scan (28). AAD was defined as any dissection that involved the aorta presenting within 14 days of symptom onset (28). The investigation protocol was approved by the Ethical Committee of the First Affiliated Hospital of Sun Yat-sen University. The basic characteristics of two groups are shown in Table 1.

TABLE 1

Table 1. Clinical and biochemical characteristics in AAD and Non-AD groups.

Data Collection and ADD-RS Assessment

Data collection for the assessment of the pretest probability of AAD were performed by a medical researcher in the Emergency Department. The tool applied to evaluate the pretest probability of AAD was the ADD-RS. The ADD-RS of AAD patient was evaluated according to the previous study (29).

The Evaluation of EPC Number and Activity

Circulating EPC number was detected by cell culture assay and flow cytometry analysis as previous studies (19, 30, 31). The EPC migration and proliferation assay was implemented according to previous studies (19, 30, 31).

Measurement of Plasma Levels of IL-6 and IL-17

Plasma levels of IL-6 and IL-17 were assessed as previously described (32, 33). According to the instructions of the manufacturer, the human IL-6, and IL-17 levels in plasma were determined by human IL-6 and IL-17 Quantikine ELISA kit (R&D Systems, Minneapolis, USA).

Statistical Analysis

All statistical analyses were carried out with SPSS 22.0. Continuous variables are represented by mean ± SD, and the comparison between two groups was analyzed by Student's t-test. Categorical variables were compared using chi-squared analysis. Pearson's coefficient (r) was used to calculate univariate correlations. If a null hypothesis could be rejected at p < 0.05, statistical significance was assumed.

Results

Baseline Characteristics

As Table 1 shows, the study population was predominantly male. The two groups were similar in terms of age and sex. The aspartate aminotransferase (AST), white blood cell (WBC), C-reactive protein (CRP), and D-dimer levels were significantly higher than those in the non-AD group (p < 0.05). There were no differences in the levels of heart rate, diastolic blood pressure, systolic blood pressure, body mass index (BMI), alanine aminotransferase (ALT), low-density lipoprotein (LDL), total cholesterol (TC), high-density lipoprotein (HDL), triglycerides (TG), blood urea nitrogen (BUN), creatinine (Cr), and cardiac troponin T (cTn-T) in the two groups (p > 0.05). In addition, according to the previous investigation for the International Registry of Acute Aortic Dissection (IRAD) Classification System to characterize survival after aortic dissection (34), the number of hyperacute patients is 19, the number of acute patients is 9, and the number of subacute patients is 6.

Circulating EPC Number and Function in AD and Non-AD Groups

Compared with the non-AD group, circulating EPC number detected by CD34+/KDR+ and DiI-acLDL/lectin double-positive cells in AAD group was reduced (Figures 1A,B). Moreover, compared with the non-AD group, EPC migration and proliferation in the AAD group were remarkably declined (Figures 1C,D).

FIGURE 1

Figure 1. The CD34+KDR+ positive cells (A) and DiI-acLDL/lectin positive cells (B) in AD subjects were lower than those in Non-AD subjects. The migratory (C) and proliferative (D) activities of EPCs in AD subjects decreased when compared with Non-AD subjects. Data are given as the mean ± standard deviation (SD). *p < 0 05 vs. Non-AD group.

EPC Number and Function in Low and High ADD-RS

According to the previous report (29), the ADD-RS is categorized as low ADD-RS group if ADD-RS ≤ 1 (defining low clinical probability of AAD) and high ADD-RS group if ADD-RS > 1 (defining high clinical probability of AAD). In our data, the number of patients with ADD-RS ≤ 1 and ADD-RS > 1 are both 17. Interestingly, the EPC number and function were found to decrease in high ADD-RS group, compared with the low ADD-RS group (Figures 2A–D).

FIGURE 2

Figure 2. The number of circulating endothelial progenitor cells (EPCs) (A,B) in high ADD-RS group were lower than that in low ADD-RS group. The migratory (C) and proliferative (D) activities in low ADD-RS group were higher than that in high ADD-RS group. Data are given as the means ± standard deviation (SD). *p < 0 05 vs. ADD risk score ≤ 1 group.

Relationship Between Characteristics of Circulating EPCs and ADD-RS

The levels of circulating CD34+/KDR+ cells (r = −0.44, p < 0.05) and DiI-acLDL/lectin double-positive cells (r = −0.50, p < 0.05) were inversely correlated with the score of ADD-RS (Figures 3A,B). In addition, we also found that the EPC migration and proliferation were inversely related to the score of ADD-RS (r = −0.40, p < 0.05, and r = −0.48, p < 0.05, respectively) (Figures 3C,D).

FIGURE 3

Figure 3. Pearson correlation ratios were used to analyze the relationship between the number or function of EPCs and ADD-RS. The CD34+KDR+ positive cells (A) and DiI-acLDL/lectin positive cells (B) significantly correlated with ADD-RS. The migratory (C) and proliferative (D) activities of EPCs were related to ADD-RS.

Plasma IL-6 and IL-17 Levels in the Two Groups

The plasma IL-6 and IL-17 level in the AAD group were higher than that in the non-AD group (Figures 4A,B).

FIGURE 4

Figure 4. (A) The plasma IL-6 level in AAD group was higher than that in Non-AD group. (B) plasma IL-17 level in AAD group was higher than that in Non-AD group. Data are given as mean ± SD. *p < 0.05 vs. Non-AD group.

Relationship Between Characteristics of Circulating EPCs and IL-6 Level

The levels of circulating CD34+/KDR+ cells (r = −0.32, p < 0.05) and DiI-acLDL/lectin double-positive cells (r = −0.54, p < 0.05) were inversely correlated with the plasma IL-6 level (Figures 5A,B). Additionally, the EPC migration and proliferation were inversely related to the plasma IL-6 level (r = −0.30, p < 0.05, and r = −0.55, p < 0.05, respectively) (Figures 5C,D).

FIGURE 5

Figure 5. Pearson correlation ratios were used to analyze the relationship between the number or function of EPCs and plasma IL-6 level. The CD34+KDR+ positive cells (A) and DiI-acLDL/lectin positive cells (B) significantly correlated with IL-6. The migratory (C) and proliferative (D) activities of EPCs were related to IL-6.

Relationship Between Characteristics of Circulating EPCs and IL-17 Level

The levels of circulating CD34+/KDR+ cells (r = −0.59, p < 0.05) and DiI-acLDL/lectin double-positive cells (r = −0.49, p < 0.05) were inversely correlated with the plasma IL-17 level (Figures 6A,B). The EPC migration and proliferation were inversely related to the plasma IL-17 level (r = −0.37, p < 0.05, and r = −0.42, p < 0.05, respectively) (Figures 6C,D).

FIGURE 6

Figure 6. Pearson correlation ratios were used to analyze the relationship between the number or function of EPCs and plasma IL-17 level. The CD34+KDR+ positive cells (A) and DiI-acLDL/lectin positive cells (B) significantly correlated with IL-17. The migratory (C) and proliferative (D) activities of EPCs were related to IL-17.

Discussion

Our study has first demonstrated that EPC number, migration, and proliferation in acute aortic dissection patients are significantly reduced. We further revealed that there is an inversely relationship between the circulating EPCs and the severity of AAD evaluated by ADD-RS exists. Moreover, the results indicated that the plasma IL-6 and IL-17 levels are increased in AAD patients and negatively correlated with EPC number or function. Taken together, the proinflammatory factor may be partly associated with the attenuated endogenous endothelial repair ability and participate in the process of AAD.

Numerous studies have indicated that the EPCs may predict outcomes in cardiovascular disease (35, 36). It has been proven that the levels of CD34+ cells are altered in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease, and the CD34+ cells were correlated with aneurysm diameter (37, 38). However, few studies focus on the relationship between circulating EPCs and AAD.

In the current study, circulating EPC number or function was investigated. All patients with acute aortic dissection involved in our study have hypertension. Our previous study discovered a dysfunction of circulating EPCs in hypertension (12, 19). Hereby, the hypertensive patients were recruited in the non-AD group to eliminate the influence of blood pressure on circulating EPCs. The results showed that AAD patients had decreased number and migration or proliferation of EPCs. However, our findings may be the different from that of Van Spyk E N's (37), and the possible reasons may be as follows: First, there is a difference in enrolled subjects. although commonly pathogenesis of AAD is atherosclerosis and share similar as the abdominal aortic aneurysm (AAA). However, vascular injury of AAD patients enrolled in our study may be more serious than that of AAA enrolled in the previous investigation. Second, we used CD34+KDR+ cells defined as EPCs, which is a frequently used and credible method to evaluate putative antigenic phenotypes of EPCs. However, the surface antigen CD34+ cells in Van Spyk E N's study, as a hematopoietic multilineage stem cell, are able to differentiate into myeloid, lymphoid, erythroid, and megakaryocytic cells (39). Third, in our study, EPCs were isolated from the peripheral blood mononuclear cells, and its migration and proliferation were also investigated.

ADD-RS may provide a simple and systematic method to screen the high likelihood of patients with AAD at the Emergency Department (ED) (40). On the basis of the ADD-RS, patients can be classified into two categories (ADD-RS ≤ 1, ADD-RS >1), which are adopted as diagnostic algorithms by international guidelines for AAD (29, 41). EPCs have been proven to be a predictive factor for cardiovascular diseases (42, 43). We revealed that EPC number or function were lower in high ADD-RS group than that in low ADD-RS group. Moreover, there is a remarkable inverse association between EPC number or function and ADD-RS. These results manifest that circulating EPCs may act as a surrogate indicator to evaluate the probability of AAD occurrence with the development of vascular diseases. In our study, the AAD patient in acute phase is defined according to a previous investigation (28). However, according to the previous investigation for the IRAD Classification System to characterize survival after aortic dissection (34), most patients are in the hyperacute or acute phase, and few patients are in the subacute phase. Our further study will be performed to investigate the effect of different classification of AD on the related alteration in circulating EPCs.

The development of AAD is proved to be accompanied by inflammation (44). However, it is not clear whether inflammation contributes to regulating the circulating EPCs in AAD. Previous studies have demonstrated that IL-6 and IL-17 take part in the mechanism of AAD (24, 27). Interestingly, our results found that IL-6 or IL-17 level had a negative correlation with EPC number and migration or proliferation in AAD, indicating the possible relationship between the proinflammatory factor and the circulating EPCs in AAD. It was reported that IL-6 has an unfavorable effect on the function of EPC after myocardial infarction (44), but it is unknown whether IL-17 can regulate the circulating EPCs. As we all know, IL-17 cytokine, produced by a novel subset of CD4+ helper T cell, has a critical effect in chronic inflammatory diseases and AAD (45) and was found to activate some common downstream signaling pathway, such as tumor necrosis factor-α (TNF-α), IL-6, and IL-1(46). The current study revealed that inflammatory-mediated endothelial repair capacity incompetency may be implicated in AAD development.

The current study has some limitations. First, this study has relatively small sample size. Further large-sample research needs to be carried out to further address it. Second, our study is designed to eliminate the influence of blood pressure on EPCs, but acute inflammation or other inflammatory disease also has an effect on EPC number and function. Our further study will be performed to elucidate it. Finally, the data of EPCs before the occurrence of AAD are difficult to acquire and not presented in this study. We will further compare the quantitative and qualitative alteration in EPCs before and after AAD in animal experiment.

In summary, our findings have some clinical implications. First, circulating EPCs may be a novel surrogate biomarker for predicting the probability of AAD. Second, the improved function of EPCs can enhance endogenous endothelial repair capacity, which may be beneficial to the prevention and treatment of AAD. For example, ACEI and ARB, significantly increasing function of EPCs, may prevent the occurrence of AAD. Third, proinflammatory factor, including IL-17 and IL-6, is involved in attenuated endogenous endothelial repair ability and may be engaged in the development of AAD. It suggests that anti-inflammatory agents such as statis and PCSK9 may be a new strategy for preventing and treating AAD.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, if it is permitted by all authors.

Ethics Statement

The studies involving human participants were reviewed and approved by the Ethical Committee of the First Affiliated Hospital of Sun Yat-sen University. The patients/participants provided their written informed consent to participate in this study.

Author Contributions

HZh and ZYa designed the research. ZH, ZL, KW, ZYe, BZ, YX, JL, LZ, HZe, and GL performed the research. ZH, ZL, KW, HZh, and ZYa analyzed the data. ZH, ZL, and ZYa wrote the paper. All authors contributed to the article and approved the submitted version.

Funding

The study was financially supported by grants from the National Natural Scientific Foundation of China (Grant Number 81670220), the Project of Science and Technology program of Guangzhou City (201803010008 and 201804010007), and the International Scientific and Technological Cooperation Project of Guangzhou Economic and Technological Development Zone (2017GH13).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

1. Ye J, Wang Y, Wang Z, Ji Q, Huang Y, Zeng T, et al. Circulating Th1, Th2, Th9, Th17, Th22, and Treg levels in aortic dissection patients. Mediat Inflamm. (2018) 2018:5697149. doi: 10.1155/2018/5697149

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Apostolakis E, Akinosoglou K. What's new in the biochemical diagnosis of acute aortic dissection: problems and perspectives. Medical Sci. Monitor. (2007) 13:RA154–8.

PubMed Abstract | Google Scholar

3. Mussa FF, Horton JD, Moridzadeh R, Nicholson J, Trimarchi S, Eagle KA. Acute aortic dissection and intramural hematoma: systematic review. JAMA. (2016) 316:754–63. doi: 10.1001/jama.2016.10026

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Cheuk BLYP, Cheng SWKM. Differential expression of elastin assembly genes in patients with stanford Type A aortic dissection using microarray analysis. J Vasc Surg. (2011) 53:1071–8. doi: 10.1016/j.jvs.2010.11.035

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss SJ, et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. (2012) 126:3070–80. doi: 10.1161/CIRCULATIONAHA.112.097097

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Yoshioka K, Yoshida K, Cui H, Wakayama T, Takuwa N, Okamoto Y, et al. Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat Med. (2012) 18:1560–9. doi: 10.1038/nm.2928

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Wenzel P, Rossmann H, Müller C, Kossmann S, Oelze M, Schulz A, et al. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. Eur Heart J. (2015) 36:3437–46. doi: 10.1093/eurheartj/ehv544

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Gimbrone MA, García-Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. (2016) 118:620–36. doi: 10.1161/CIRCRESAHA.115.306301

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Fan LM, Douglas G, Bendall JK, McNeill E, Crabtree MJ, Hale AB, et al. Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation. (2014) 129:2661–72. doi: 10.1161/CIRCULATIONAHA.113.005062

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Wang K, Zhao J, Zhang W, Zhu M, Xu M, Li D, et al. Resveratrol attenuates aortic dissection by increasing endothelial barrier function through the SIRT1 pathway. J Cardiovasc Pharmacol. (2020) 76:86–93. doi: 10.1097/FJC.0000000000000837

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Sipos PI, Crocker IP, Hubel CA, Baker PN. Endothelial progenitor cells: their potential in the placental vasculature and related complications. Placenta. (2010) 31:1–0. doi: 10.1016/j.placenta.2009.10.006

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Bai Y, Xiao S, Tang Y, Tan Z, Tang H, Ren Z, et al. Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells. J Hypertens. (2017) 35:784–97. doi: 10.1097/HJH.0000000000001216

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Medina RJ, O'Neill CL, Humphreys MW, Gardiner TA, Stitt AW. Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy. Invest Ophth Vis Sci. (2010) 51:5906–13. doi: 10.1167/iovs.09-4951

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Ikutomi M, Sahara M, Nakajima T, Minami Y, Morita T, Hirata Y, et al. Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation. J Mol Cell Cardiol. (2015) 86:121–35. doi: 10.1016/j.yjmcc.2015.07.019

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Dei Cas A, Spigoni V, Ardigò D, Pedrazzi G, Franzini L, Derlindati E, et al. Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men. Nutr Metab Cardiovasc Dis. (2011) 21:512–7. doi: 10.1016/j.numecd.2009.11.011

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvàth T, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. (2010) 55:1389–97. doi: 10.1161/HYPERTENSIONAHA.109.141614

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Lee PS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells. (2014) 6:355–66. doi: 10.4252/wjsc.v6.i3.355

CrossRef Full Text | Google Scholar

18. Yang Z, Xiao S, Ren Z, Shen HW, Su H, Tang YB, et al. Increased endothelial progenitor cells and nitric oxide in young prehypertensive women. J Clin Hypertens. (2015) 17:298–305. doi: 10.1111/jch.12493

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Yang Z, Chen L, Su C, Xia WH, Wang Y, Wang JM, et al. Impaired endothelial progenitor cell activity is associated with reduced arterial elasticity in patients with essential hypertension. Clin Exp Hypertens. (2010) 32:444–52. doi: 10.3109/10641961003686435

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Gu J, Hu J, Qian H, Shi Y, Zhang E, Guo Y, et al. Intestinal barrier dysfunction. J Cardiovasc Pharmcol Ter. (2015) 21:64–9. doi: 10.1177/1074248415581176

CrossRef Full Text | Google Scholar

21. Del Porto F, Proietta M, Tritapepe L, Miraldi F, Koverech A, Cardelli P, et al. Inflammation and immune response in acute aortic dissection. Ann Med. (2010) 42:622–9. doi: 10.3109/07853890.2010.518156

PubMed Abstract | CrossRef Full Text | Google Scholar

22. He R, Guo D, Estrera AL, Safi HJ, Huynh TT, Yin Z, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. (2006) 131:671–8. doi: 10.1016/j.jtcvs.2005.09.018

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Wen D, Zhou X, Li J, Luo F, Zhang L, Gao L, et al. Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection. Clin Chim Acta. (2012) 413:198–202. doi: 10.1016/j.cca.2011.09.029

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Ju X, Ijaz T, Sun H, Ray S, Lejeune W, Lee C, et al. Interleukin-6–signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17–Interleukin 17 axis in C57BL/6 mice. Arterioscler Thromb Vasc Biol. (2013) 33:1612–21. doi: 10.1161/ATVBAHA.112.301049

PubMed Abstract | CrossRef Full Text | Google Scholar

25. von Vietinghoff S, Ley K. Interleukin 17 in vascular inflammation. Cytokine Growth Factor Rev. (2010) 21:463–9. doi: 10.1016/j.cytogfr.2010.10.003

CrossRef Full Text | Google Scholar

26. Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, et al. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e–Deficient mice. Arterioscler Thromb Vasc Biol. (2011) 31:1565–72. doi: 10.1161/ATVBAHA.111.227629

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Sawada H, Gong MC, Guo Z, Daugherty A, Lu HS. High salt and IL (Interleukin)-17 in aortic dissection. Arterioscler Thromb Vasc Biol. (2020) 40:17–9. doi: 10.1161/ATVBAHA.119.313654

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. (2000) 283:897–903. doi: 10.1001/jama.283.7.897

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Nazerian P, Mueller C, Soeiro ADM, Leidel BA, Salvadeo SAT, Giachino F, et al. Diagnostic accuracy of the aortic dissection detection risk score plus D-Dimer for acute aortic syndromes. Circulation. (2018) 137:250–8. doi: 10.1161/CIRCULATIONAHA.117.029457

CrossRef Full Text | Google Scholar

30. Yang Y, Tian J, Deng L, Ong JL. Morphological behavior of osteoblast-like cells on surface-modified titanium in vitro. Biomaterials. (2002) 23:1383–9. doi: 10.1016/S0142-9612(01)00259-9

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Yang Z, Xia WH, Su C, Wu F, Zhang YY, Xu SY, et al. Regular exercise-induced upregulation of circulating endothelial progenitor cells attenuated age-related decline in arterial elasticity in healthy men. Int J Cardiol. (2013) 165:247–54. doi: 10.1016/j.ijcard.2011.08.055

CrossRef Full Text | Google Scholar

32. Liu Y, Zhao Q, Yin Y, McNutt MA, Zhang T, Cao Y. Serum levels of IL-17 are elevated in patients with acute gouty arthritis. Biochem Biophys Res Commun. (2018) 497:897–902. doi: 10.1016/j.bbrc.2018.02.166

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Kiriakopoulos N, Grigoriadis S, Maziotis E, Philippou A, Rapani A, Giannelou P, et al. Investigating stress response during vaginal delivery and elective cesarean section through assessment of levels of cortisol, interleukin 6 (IL-6), growth hormone (GH) and insulin-like growth factor 1 (IGF-1). J Clin Med. (2019) 8:1112. doi: 10.3390/jcm8081112

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Booher AM, Isselbacher EM, Nienaber CA, Trimarchi S, Evangelista A, Montgomery DG, et al. The IRAD classification system for characterizing survival after aortic dissection. Am J Med. (2013) 126:730.e19-24. doi: 10.1016/j.amjmed.2013.01.020

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Lee HJ, Kim W, Kim WS, Woo JS, Kim YG, Moon JY, et al. Circulating endothelial progenitor cell levels predict cardiovascular events in end-stage renal disease patients on maintenance hemodialysis. Nephron. (2015) 130:151–8. doi: 10.1159/000430471

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Rigato M, Avogaro A, Fadini GP. Levels of circulating progenitor cells, cardiovascular outcomes and death. Circ Res. (2016) 118:1930–9. doi: 10.1161/CIRCRESAHA.116.308366

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Shimoni S, Bar I, Meledin V, Derazne E, Gandelman G, George J. Circulating endothelial progenitor cells and clinical outcome in patients with aortic stenosis. PLos ONE. (2016) 11:e148766. doi: 10.1371/journal.pone.0148766

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Van Spyk EN, Chun KC, Samadzadeh KM, Peters JH, Lee ES. Increased levels of CD34+ cells are associated in patients with abdominal aortic aneurysms compared with patients with peripheral vascular disease. J Surg Res. (2013) 184:638–43. doi: 10.1016/j.jss.2013.03.070

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Parietti E, Pallandre J, Deschaseaux F, Aupècle B, Durst C, Kantelip J, et al. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor-1α are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg. (2011) 40:e6–12. doi: 10.1016/j.ejcts.2011.02.065

PubMed Abstract | CrossRef Full Text | Google Scholar

40. RK B. Clinical Utility in Maximizing CD34+ in Stem Cell Grafts. Stem Cells. (1999) 17:373–6. doi: 10.1002/stem.170373

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Rogers AM, Hermann LK, Booher AM, Nienaber CA, Williams DM, Kazerooni EA, et al. Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation. Circulation. (2011) 123:2213–8. doi: 10.1161/CIRCULATIONAHA.110.988568

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Qiu Y, Zhang C, Zhang G, Tao J. Endothelial progenitor cells in cardiovascular diseases. Aging Med. (2018) 1:204–8. doi: 10.1002/agm2.12041

CrossRef Full Text | Google Scholar

43. Grisar JC, Haddad F, Gomari FA, Wu JC. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med. (2011) 5:731–44. doi: 10.2217/bmm.11.92

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Shahrivari M, Wise E, Resende M, Shuster JJ, Zhang J, Bolli R, et al. Peripheral blood cytokine levels after acute myocardial infarction: IL-1beta- and IL-6-Related impairment of bone marrow function. Circ Res. (2017) 120:1947–57. doi: 10.1161/CIRCRESAHA.116.309947

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Luo F, Zhou X, Li J, Hui R. Inflammatory response is associated with aortic dissection. Ageing Res Rev. (2009) 8:31–5. doi: 10.1016/j.arr.2008.08.001

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Simon T, Taleb S, Danchin N, Laurans L, Rousseau B, Cattan S, et al. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J. (2013) 34:570–7. doi: 10.1093/eurheartj/ehs263

PubMed Abstract | CrossRef Full Text | Google Scholar